Hepatitis B Virus
Murine offspring fare well when pregnant mice receive lamivudine therapy
Published in Hepatitis Weekly, June 20th, 2005
According to recent research from the People's Republic of China, "previous studies reported that the HBV DNA level in maternal serum is an important risk factor for intrauterine infection. Two antiviral drugs, lamivudine (3TC) and interferon alpha (IFN alpha), are used extensively clinically to reduce maternal HBV DNA level, however, because of a lack of evidence on the efficacy and safety of these drugs during pregnancy, they are categorized as grade C, which prevents their use during pregnancy."
"This study provides new data on the efficacy and safety of lamivudine and IFN...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-06-20)
More Articles from Hepatitis Weekly
- Diagnostics
SSCP analysis is a quick investigatory tool for hepatitis A outbreaks - Diagnostics
Salivary screening monitors chronic hepatitis C patients for viral clearance - Hepatitis A Therapy
Small interfering RNAs disrupt hepatitis A virus replication - Oncology
Glypican-3 diagnoses human cancers and could be targeted for tumor prevention - Addiction Medicine
New findings in the area of addiction medicine detailed - Adverse Drug Reaction
Anti-tuberculosis drugs correlate with severe liver toxicity in Spain - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
